Morgan Stanley maintains NXP Semiconductors (NASDAQ:NXPI) with a Equal-Weight and lowers the price target from $262 to $188.
Piper Sandler Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $2
Piper Sandler analyst Do Kim maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $1 to $2.